Hansson Göran K, Nilsson Jan
Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital L8:03, Stockholm, 17176, Sweden.
Semin Immunopathol. 2009 Jun;31(1):95-101. doi: 10.1007/s00281-009-0151-x. Epub 2009 May 26.
Atherosclerosis involves the formation of inflammatory arterial lesions and is one of the most common causes of death globally. It has been evident for more than 20 years that adaptive immunity regulates the magnitude of the atherogenic proinflammatory response. T cells may also influence the stability of the atherosclerotic lesion and thus the propensity for thrombus formation and the clinical outcome of disease. Immunization of hypercholesterolemic animals with low-density lipoprotein preparations reduces atherosclerosis, suggesting that vaccination may represent a useful strategy for disease prevention or modulation. This review summarizes our current understanding of the role immunity in atherosclerosis and outlines strategies for antigen-specific prevention of this disease.
动脉粥样硬化涉及炎症性动脉病变的形成,是全球最常见的死亡原因之一。二十多年来一直很明显的是,适应性免疫调节致动脉粥样硬化促炎反应的程度。T细胞也可能影响动脉粥样硬化病变的稳定性,从而影响血栓形成的倾向和疾病的临床结果。用低密度脂蛋白制剂对高胆固醇血症动物进行免疫可减轻动脉粥样硬化,这表明疫苗接种可能是预防或调节该疾病的一种有用策略。本综述总结了我们目前对免疫在动脉粥样硬化中作用的理解,并概述了针对该疾病进行抗原特异性预防的策略。